DSR-141562 is novel Phosphodiesterase 1 Inhibitor for the Treatment of Positive Symptoms, Negative Symptoms and Cognitive Impairments Associated with Schizophrenia.
For research use only. We do not sell to patients.
Name | DSR-141562 |
---|---|
Iupac Chemical Name | [3-Methyl-7-(tetrahydro-2H-pyran-4-yl)-2-{[trans-4-(trifluoromethyl)cyclohexyl]- methoxy}imidazo[5,1-f][1,2,4]triazin-4(3H)-one] |
Synonyms | DSR-141562 ; DSR 141562 ; DSR141562 |
Molecular Formula | C19H25F3N4O3 |
Molecular Weight | 414.42 |
Smile | O=C1N(C)C(OC[C@H]2CC[C@H](C(F)(F)F)CC2)=NN3C1=CN=C3C4CCOCC4 |
InChiKey | LNELWUPBSLZUIQ-MQMHXKEQSA-N |
InChi | InChI=1S/C19H25F3N4O3/c1-25-17(27)15-10-23-16(13-6-8-28-9-7-13)26(15)24-18(25)29-11-12-2-4-14(5-3-12)19(20,21)22/h10,12-14H,2-9,11H2,1H3/t12-,14- |
CAS Number | 2007975-22-4 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder 6 months-80ºCin solvent |
Solubility | Soluble in DMSO to 20 mM |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping. |
HS Code |
Targets | PDE1 inhibitor |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |